NIKITIN, A.G.,
CHUDAKOVA, D.A.,
ENIKEEV, R.F.,
GORDIEV, M.G.,
SAKAEVA, D.,
DRUZHKOV, M.,
SHIGAPOVA, L.H.,
BROVKINA, O.I.,
SHAGIMARDANOVA, E.I.,
GUSEV, O.A. (2020) that LS-mutations are present in patients with hereditary BC more
frequently than in healthy donors
Zagidullin, N.,
Plechev, V.,
Badykova, E.,
Badykov, M.,
Akhmadishina, L.,
Korytina, G.,
Sagitov, I. (2019) was of statistical significance (χ2 = 8.40, P = 0.02), so the T/T genotype was more
frequent in the control group, 15
Wu, JN,
Al-Zahrani, A,
Beylerli, O,
Sufianov, R,
Talybov, R,
Meshcheryakova, S,
Sufianova, G,
Gareev, I,
Sufianov, A (2022) on microRNAs (miRNAs) expression profiling in glioma and highlighted the most
frequently dysregulated mi
V.N. Pavlov,
Beylerli, O.,
Gareev, I.,
Torres Solis, L.F.,
Solís Herrera, A.,
Aliev, G. (2020) the possible pathophysiological mechanisms of COVID-19
infection in patients with ICH. © Copyright © 2020
FEDOROVA, Y.Y.,
KARUNAS, A.S.,
GIMALOVA, G.F.,
KHUSNUTDINOVA, E.K.,
SAVELIEVA, O.N,
MURZINA, R.R.,
GATIYATULLIN, R.F.,
ETKINA, E.I. (2019) with the rs37973 AG and rs37973 GG genotypes of the GLCCI1 gene compared with
children with rs37973 AA
on
initial CD4 distribution at
infection, CD4 progression rates (probability of progression from higher
Yang, L.,
Luo, W.,
Zhang, Q,
Hong, S.,
Wang, Y.,
Samorodov, A.V.,
Chattipakorn, N.,
Pavlov, V.N.,
Liang, G. (2021) by DH5α bacterial
infection. Conclusion: We demonstrate that a natural product, CAR, attenuates LPS